Minimally Invasive Circumferential Hiatal Dissection for the Treatment of Adenocarcinoma of the Distal Esophagus and Esophago-gastric Junction: Technical Considerations Combined With Histopathological Outcomes.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 14 04 2019
revised: 04 05 2019
accepted: 08 05 2019
entrez: 10 6 2019
pubmed: 10 6 2019
medline: 18 6 2019
Statut: ppublish

Résumé

Circumferential resection margin involvement is an independent prognostic factor in patients with adenocarcinoma of the distal esophagus and esophago-gastric junction. However, there is currently no consensus on the extent and the technique of hiatal dissection. We describe a minimally invasive technique of circumferential hiatal dissection for adenocarcinoma of the distal esophagus and esophago-gastric junction with its related histopathological results. A prospective study of 40 consecutive patients undergoing hybrid (laparoscopic/thoracotomic) or totally minimally invasive Ivor-Lewis esophagogastrectomy over a period of 21 months was conducted. Dissection of the hiatus included peri-esophageal surrounding tissues in a cylindrical fashion maximizing the distance from the oesophageal wall. Crural muscle fibers and pleura bilaterally, pericardial fat anteriorly and pre-aortic tissue posteriorly were excised en bloc. Histopathological results particularly focused on involvement of the circumferential resection margin. Neoadjuvant chemotherapy was given to 24 (60%) patients. Complete histological clearance (R0) was achieved in 92.5% (n=37) according to the criteria of the College of American Pathologists and in 87.5% (n=35) according to those of the Royal College of Pathologists. In pT3 tumors (n=22), the circumferential resection margin was negative in 20 patients (91%) according to the College of American Pathologists, and in 17 (77%) according to the Royal College of Pathologists. Adoption of this safe and reproducible technique might reduce the incidence of circumferential resection margin involvement and improve pathological outcomes. In addition, there may be positive implications for training and quality control.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Circumferential resection margin involvement is an independent prognostic factor in patients with adenocarcinoma of the distal esophagus and esophago-gastric junction. However, there is currently no consensus on the extent and the technique of hiatal dissection. We describe a minimally invasive technique of circumferential hiatal dissection for adenocarcinoma of the distal esophagus and esophago-gastric junction with its related histopathological results.
PATIENTS AND METHODS METHODS
A prospective study of 40 consecutive patients undergoing hybrid (laparoscopic/thoracotomic) or totally minimally invasive Ivor-Lewis esophagogastrectomy over a period of 21 months was conducted. Dissection of the hiatus included peri-esophageal surrounding tissues in a cylindrical fashion maximizing the distance from the oesophageal wall. Crural muscle fibers and pleura bilaterally, pericardial fat anteriorly and pre-aortic tissue posteriorly were excised en bloc. Histopathological results particularly focused on involvement of the circumferential resection margin. Neoadjuvant chemotherapy was given to 24 (60%) patients.
RESULTS RESULTS
Complete histological clearance (R0) was achieved in 92.5% (n=37) according to the criteria of the College of American Pathologists and in 87.5% (n=35) according to those of the Royal College of Pathologists. In pT3 tumors (n=22), the circumferential resection margin was negative in 20 patients (91%) according to the College of American Pathologists, and in 17 (77%) according to the Royal College of Pathologists.
CONCLUSION CONCLUSIONS
Adoption of this safe and reproducible technique might reduce the incidence of circumferential resection margin involvement and improve pathological outcomes. In addition, there may be positive implications for training and quality control.

Identifiants

pubmed: 31177171
pii: 39/6/3219
doi: 10.21873/anticanres.13462
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3219-3225

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Bruno Lorenzi (B)

Regional Center for Oesophagogastric Cancer, Department of Upper Gastrointestinal Surgery, Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, U.K.

Spyridon Davakis (S)

Regional Center for Oesophagogastric Cancer, Department of Upper Gastrointestinal Surgery, Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, U.K. spdavakis@gmail.com.

Athanasios Syllaios (A)

Regional Center for Oesophagogastric Cancer, Department of Upper Gastrointestinal Surgery, Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, U.K.

Ali Kordzadeh (A)

Regional Center for Oesophagogastric Cancer, Department of Upper Gastrointestinal Surgery, Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, U.K.

Moina Kadri (M)

Department of Pathology, Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, U.K.

Manisha Ram (M)

Department of Pathology, Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, U.K.

Khaleel Fareed (K)

Department of Surgery, Derby Teaching Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, U.K.

Charlotte Barter (C)

Department of Surgery, Derby Teaching Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, U.K.

Alexandros Charalabopoulos (A)

Regional Center for Oesophagogastric Cancer, Department of Upper Gastrointestinal Surgery, Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH